By IQT News posted 11 Jan 2022

(ProactiveInvestors) Archer Materials Ltd (ASX:AXE, OTC:ARRXF) has set the stage to play an important role in helping the technology sector meet growing global expectations after completing what it describes as a “special year” in 2021.
The company is focused on developing its 12CQ quantum computing qubit processor chip and biochip technology with both seeing step-change achievements made in the past 12 months.
Archer is well-placed to play an increasing role in technology development during 2022 having passed a number of milestones in 2021, including:

Patents related to the 12CQ quantum computing chip technology were granted in Japan, South Korea, China and USA.
Signed a new agreement with IBM, an LOI with The Australian Missile Corporation, an MOU with The Australian Institute for Machine Learning and made significant progress with fellow IBM Quantum Network member Max Kelsen.
The company’s mineral exploration tenements were sold and Archer was admitted to the S&P/ASX All Technology Index – as a pure-play deep tech.
Capital was raised to grow the company through the support of global institutional investors and existing shareholders which sees Archer well-funded in the year ahead.
Choucair said: “Archer has made considerable progress in the development of our 12CQ quantum computing qubit processor chip, a world-first qubit processor technology that could allow for quantum computing powered mobile devices (QPMDs).

“We are excited to build on this progress in 2022 and I look forward to updating on Archer’s deep-tech developments, and hopefully, demystify quantum along the way,” said AXE’s chief executive officer Dr Mohammad Choucair

Subscribe to Our Email Newsletter

Stay up-to-date on all the latest news from the Quantum Technology industry and receive information and offers from third party vendors.

0